• Citer

Tumor PIK3CA mutations, lymphocyte infiltration, and recurrence-free survival (RFS) in early breast cancer (BC): Results from the FinHER trial

par Loi, Sherene ;Michiels, Stefan ;Lambrechts, Diether;Salgado, Roberto;Sirtaine, Nicolas;Fumagalli, Debora ;Claes, B.;Kellokumpu-Lehtinen, P-L;Bono, Petri;Kataja, Vesa;Larsimont, Denis ;Piccart-Gebhart, Martine ;Joensuu, Heikki;Sotiriou, Christos
Référence ASCO Annual Meeting 2012(June 1 - 5, 2012: Chicago, Il, USA), J Clin Oncol, ASCO Annual Meeting Proceedings, Vol. vol 30, issue 18 suppl
Publication Publié, 2012-06

Abstract de conférence

• Détails
• Contenu

Titre:	Tumor PIK3CA mutations, lymphocyte infiltration, and recurrence-free survival (RFS) in early breast cancer (BC): Results from the FinHER trial
Auteur:	Loi, Sherene; Michiels, Stefan; Lambrechts, Diether; Salgado, Roberto; Sirtaine, Nicolas; Fumagalli, Debora; Claes, B.; Kellokumpu-Lehtinen, P-L; Bono, Petri; Kataja, Vesa; Larsimont, Denis; Piccart-Gebhart, Martine; Joensuu, Heikki; Sotiriou, Christos
Informations sur la publication:	ASCO Annual Meeting 2012(June 1 - 5, 2012: Chicago, Il, USA), J Clin Oncol, ASCO Annual Meeting Proceedings, Vol. vol 30, issue 18 suppl
Statut de publication:	Publié, 2012-06
Sujet CREF:	Cancérologie
	Médecine pathologie humaine
Langue:	Anglais